BlockBeats News, July 15th, according to market data, the Hong Kong-listed company Sino Biopharmaceutical (HK0399) surged more than 10% intraday, with a trading volume of 8 million Hong Kong dollars.
Sino Biopharmaceutical had previously announced plans to acquire all the shares of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.